학술논문
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
Document Type
Article
Author
Tivey, A.; Shotton, R.; Chaturvedi, A.; Linton, K.; Gibb, A.; Sharpley, F.; Eyre, T.A.; Lewis, D.; Crosbie, N.; Stanton, L.; Allchin, R.; Walter, H.; Miall, F.; Zhao, R.; Lord, A.; Jackson, B.; Santarsieri, A.; McCulloch, R.; Bishton, M.; Beech, A.; Willimott, V.; Fowler, N.; Bedford, C.; Everden, A.; Tucker, D.; Goddard, J.; Wright, J.; Protheroe, S.; Dukka, V.; Reeve, M.; Owen, M.; Paneesha, S.; Prahladan, M.; Hodson, A.; Koppana, M.; Qureshi, I.; Ediriwickrema, K.; Lambert, J.; Mohamedbhai, S.; Marr, H.; Wilson, J.; Wrench, D.; Burney, C.; Knott, C.; Talbot, G.; Phillips, N.; Stern, S.; Sutton, T.; Webb, A.; Wilson, M.; Thomas, N.; Norman, J.; Davies, E.; Lowry, L.; Flont, M.; Nga, E.; Virchis, A.; Camacho, R.G.; Swe, W.; Pillai, A.; Rees, C.; Moule, S.; Bailey, J.; Jones, S.; Smith, S.; Hildyard, C.; Nicholson, T.; Maddox, J.
Source
In: Blood Advances . (Blood Advances, 12 March 2024, 8(5):1209-1219)
Subject
Language
English
ISSN
24739537
24739529
24739529